New clinical trial tests gene therapy vector for overactive bladder in SCI patients
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial (external link) by UTHealth Houston at TIRR Memorial Hermann. Neurogenic bladder, also called…
Pages